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Abstract
Background: The aim of the study was to compare in our center the effect of different ablation 
techniques on intermediate term freedom from atrial fibrillation (AF) or atrial tachycardia (AT) 
in  patients  affected  by  refractory  AF.                              
Methods and Results: We retrospectively selected 94 patients who underwent AF ablation in 
our electrophysiological laboratory from June 2007 to December 2009. 29 patients underwent 
manual  circumferential  pulmonary  vein  isolation  (mCPVI),  35  underwent  remote  magnetic 
navigation assisted CPVI (rmtCPVI) and 30 cryoballoon CPVI (cCPVI). Antiarrhythmic drugs 
were systematically stopped 2 months after the procedure (end of the "blanking period").    
At a mean follow-up of 12,64 ± 6,41 months (range 2-31), the success rate for mCPVI group 
was 65.5% (19 patients), 66.7 % (20 patients) for the rmtCPVI group and 65.7 % (23 patients)  
for the cCPVI group (p = 0.625). Procedural and fluoroscopy times were significantly reduced 
in  the  cCPVI  group  (both  p  <  0.001).  Univariate  Cox  regression  showed  that  no  clinical 
variables  were  independently  associated  with  recurrence.                                  
Conclusions: In our center's experience cCPVI and rmtCPVI have been demonstrated to be as 
effective as mCPVI. cCPVI seemed to be associated with lower procedural and fluoroscopy 
times.
Keywords: atrial fibrillation; ablation; remote magnetic navigation; cryoballoon                   
Introduction
Since  the  demonstration  that  pulmonary  vein  (PV)  ectopic  activity  is  the  main  trigger  of 
paroxysmal atrial fibrillation (AF) [1,2] percutaneous transcatheter ablation of this arrhythmia 
has become an increasingly used procedure for the treatment of this arrhythmia. Today, isolation 
of the PVs represents am established approach when performing AF ablation [1,2]. 
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 10 (11): 486-495 (2010)
Antonio Sorgente, Gian Battista Chierchia, Lucio Capulzini, Yoshinao Yazaki,        487 
Andreas  Muller-Burri,  Fatih  Bayrak,  Andrea  Sarkozy,  Carlo  de  Asmundis,  Gaetano 
Paparella,  Pedro  Brugada,  “Atrial  Fibrillation  Ablation:  A  Single  Center  Comparison  
Between Remote Magnetic Navigation, Cryoballoon and Conventional Manual Pulmonary  
Vein Isolation”
Traditionally, PV isolation (PVI) is achieved with a 'point by point' ablation technique by means 
of  radiofrequency  (RF)  energy.  Recently,  novel  technologies  such  as  remote  magnetic 
navigation (RMT) ablation and cryoballoon ablation have been demonstrated to be feasible and 
reliable  in  achieving  PVI  [3,4].                                 
Three dimensional electroanatomically guided conventional manual RF ablation (mCPVI), 3D 
electroanatomically  guided RMT RF ablation  (rmtCPVI)  and cryoballoon ablation  (cCPVI). 
Compared  to  mCPVI,  rmtCPVI  and  cCPVI  might  offer  advantages  in  terms  of  procedure 
reproducibility and operator comfort. RmtCPVI enables the operator to direct in virtually any 
direction a flexible mapping catheter in the heart by the means of the movements of a computer 
mouse. This is rendered possible by slight variations in the magnetic field created by 2 activated 
magnets  positioned at  the patients  side.  The movements  of  the catheter  are  precise and the 
operator comfort optimal. The cCPVI technique permits PVI in more than 90% of veins [3]. The 
technique consists of inflating an over the catheter balloon in the LA and then wedging it in the 
PV ostium. Once total occlusion is demonstrated by the means of dye injection, cryoablation 
application can be started. The balloon will tightly adhere to the tissue during cryoablation. This 
might lead to better outcome when ablating particular anatomical structures, such as the ridge 
between  the  LSPV  and  the  LAA  by  offering  better  contact.  This  technology  permits  a 
straightforward approach to atrial fibrillation ablation that might be less affected by operator 
skills  as  compared  to  the  traditional  point  by  point  approach  with  a  focal  tip  catheter.
Moreover,  these  new  techniques  might  also  offer  better  procedure  reproducibility,  reduce 
radiation  exposure  time  and  operator  fatigue  when  compared  to  manual  conventional  PVI. 
However, a comparison of the results following PVI with these different techniques is lacking. 
The aim of our study was to compare the short-term and mid-term outcome of PVI using three 
distinct  technologies:  RMT ablation,  cryoballoon ablation  and conventional  manual  ablation 
technique.
Methods
We retrospectively analyzed all the patients referred to our department for documented drug 
refractory  symptomatic  AF that  underwent  a  single  PVI  procedure  between June  2007 and 
December 2009. To ensure a reasonable comparison of the 3 techniques and to diminish the 
influence of a learning curve on outcome, only operators' experience with > 30 patients using 
each technique was included and the first 5 patients undergoing PVI with each technique were 
excluded from our analysis. Procedural end point in all procedures was considered achievement 
of  electrophysiologically  proven  PVI.  Paroxysmal  AF  was  defined  as  self-terminating  AF 
episodes lasting less than 7 days. Persistent AF was defined as AF episodes lasting > 7 days or 
requiring  pharmacological  or  electrical  cardioversion  because  of  intolerable  symptoms. 
Permanent AF was defined when AF was the sole rhythm for the last 6 months. As mentioned  
above, 3 techniques were used to treat these patients: mCPVI, rmtCPVI and cCPVI. Patients 
were excluded from our retrospective analysis if they had already undergone a previous AF 
ablation procedure, in case of the occurrence of an acute complication that impeded procedure 
termination,  in  case  of  cross-over  from rmtCPVI  to  mCPVI,  in  case  additional  "touch-up" 
applications with a focal catheter if PVI could not be reached using solely the cryoballoon, if 
additional linear ablation or ablation of complex fractionated atrial electrograms (CFAE) was 
performed, in case of absence of follow-up and if the patient already participated in the past 
and/or  was  included  in  another  ongoing  study  in  our  center.                         
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All  ablations  were  performed  under  general  anesthesia.  Prior  to  the  procedure,  all  patients 
underwent  a  2D  transthoracic  echocardiogram  (TTE)  to  evaluate  left  ventricular  ejection 
fraction and to exclude any structural and/or valvular disease. A cardiac computed tomography 
(CT) and a transesophageal echocardiography (TEE) were performed the day before ablation in 
order to evaluate left atrial and PV anatomy and to exclude the presence of intracardiac thrombi. 
Ablation  procedure                                                     
mCPVI  procedure                                       
A 6F pigtail catheter was positioned in the aortic root via a left femoral approach, to monitor 
arterial  pressure  and  to  assess  the  radiological  position  of  the  aorta.  A  6F  quadripolar  or 
decapolar  catheter  were  inserted  in  the  right  jugular  vein  or  in  the  left  femoral  vein  and 
advanced into the coronary sinus (CS). A double transseptal puncture was then performed under 
fluoroscopic  guidance,  using  the  right  femoral  venous  approach.  Following  this,  the  2 
transseptal sheaths were advanced over the guide wires into the left atrium (LA). After gaining 
double left atrial access, a 70 UI/Kg heparin iv bolus was given. A selective angiogram in each 
PV in  order  to  delineate  the  ostium was  then  performed.  Next,  a  circumferential  mapping 
catheter (LassoTM, Biosense Webster Inc., Diamond Bar, CA, USA) was introduced into the 
proximal PVs to gather baseline electrical information. Three-dimensional left atrial maps were 
reconstructed using a non-fluoroscopic navigation system (CARTOTM, Biosense Webster Inc., 
Diamond  Bar,  CA,  USA).  Maps  were  acquired  during  sinus  rhythm  or  AF.  After  map 
completion, RF energy was applied through a 3.5 mm irrigated tip ablation catheter (Navistar, 
ThermocoolTM, Biosense Webster, Inc., Diamond Bar, CA, USA) in a power-controlled mode 
with a power limit of 35 Watts and a maximum temperature of 48◦C. Each application lasted for 
a maximum of 60 s. Power was decreased to 25W when ablating on the posterior wall in order 
to avoid oesophageal injury. Ablation was continued at each point until the amplitude of the 
bipolar electrogram was reduced by 80% or decreased below 0.2 mV. No additional ablation 
lines were performed. The ablation strategy was to create contiguous focal lesions at a distance 
> 5 mm from the ostia of the PVs, thereby forming a circumferential line of conduction block 
around ipsilateral PVs with a circumferential mapping catheter (LassoTM, Biosense Webster Inc., 
Diamond Bar, CA, USA) placed in the PV ostium for PV potentials mapping. If PVI could not 
be  achieved after  completion  of  the  circumferential  ablation,  further  targeting  the  electrical 
breakthroughs on the ablation line was performed until complete isolation could be documented.
cCPVI  procedure                                            
A 6F pigtail catheter was positioned in the aortic root via a left femoral approach, to monitor 
arterial  pressure  and  to  assess  the  radiological  position  of  the  aorta.  A  6F  quadripolar  or 
decapolar catheter was inserted in the right jugular vein or in the left femoral vein and advanced 
to the CS. A single transseptal puncture was then performed under fluoroscopic guidance, using 
the right femoral venous approach. After gaining left atrial access, a 70 UI/Kg heparin iv bolus 
was  given.  A  selective  angiogram  in  each  PV  in  order  to  delineate  the  ostium  was  then 
performed. Immediately after, a 0.032" 260 cm long guide-wire (Emerald, Cordis, Johnson & 
Johnson, Diamond Bar,  California,  USA) was advanced in the left  superior pulmonary vein 
(LSPV) and  a  steerable  15  F  over-the-wire  sheath  (FlexCath,  Cryocath,  Montreal,  Quebec, 
Canada) was positioned in the LA. A circular mapping catheter (Lasso, Biosense Webster, Inc., 
Diamond Bar CA, USA) was then advanced in each PV ostium to obtain baseline electrical 
information.  After  withdrawing  the  mapping  catheter,  a  28  mm double  walled  cryoballoon 
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(Arctic Front, Cryocath, Montreal, Quebec, Canada) was advanced over the wire up to the LA, 
inflated and positioned in the PV ostium of each vein. Optimal vessel occlusion was considered 
to have been achieved when selective contrast injection showed total contrast retention with no 
flow to the atrium. For each vein, cryoablation consisted of a minimum of 2 applications lasting 
5 minutes each. Whenever possible, we tried to engage with the guide-wire 2 different branches 
of the same vein and to orient the balloon differently, in the attempt of covering a wider ostial 
surface.  However,  if  successful  occlusion  could  only  be  obtained  in  one  branch,  both 
applications where delivered by leaving the guide-wire in the same branch. Usually, the LSPV 
was treated first, followed by the left inferior (LIPV), right superior (RSPV) and right inferior 
(RIPV). In order to avoid phrenic nerve palsy, a complication observed during RSPV isolation 
with CBA, a quadripolar catheter was inserted in the superior vena cava and diaphragmatic 
stimulation was achieved by pacing the ipsilateral phrenic nerve with a 1000 ms cycle and a 12 
mA pulse output. The reason of pacing at such a slow rate was to prevent catheter displacement 
in the early phases of application due to diaphragmatic contraction. After ablation in all PVs, the 
circular mapping catheter (Lasso, Biosense Webster, Inc., Diamond Bar CA, USA) was then 
placed  in  each  ostium  to  evaluate  isolation.  In  case  of  persistence  of  PV  potentials  extra 
cryoballoon applications were performed until complete PVI.                                  
rmtCPVI  procedure                                    
The procedure was performed as in the manual RF ablation group with the exception that left 
atrial electroanatomic mapping and RF ablation were performed by using an integrated CARTO 
RMT system (Biosense-Webster,  Inc.,  Diamond Bar  CA,  USA) together  with  the  Niobe II 
remote magnetic system. CARTO-RMT integration procedure, magnetic navigation procedure 
and remote mapping were identical to those previously described by Pappone and coworkers 
[4], except that we used an irrigated 3.5 mm ablation catheter  (Thermocool RMT NaviStar, 
Biosense Webster,  Diamond Bar,  California)  instead of a 4 mm flexible  catheter  (NaviStar-
RMT,  Biosense  Webster,  Diamond  Bar,  California).  The ablation  protocol  was  identical  to 
conventional  manual  RF ablation  (see  description  above).                                 
Follow-up and  postablation  clinical  strategy                                          
2D TTE was repeated the day after the procedure in order to evaluate the mitral valve and the 
left ventricular ejection fraction, and to exclude the presence of pericardial effusion. All patients 
were discharged on oral anticoagulation with a target international normalized ratio between 2 
and  3  and  on  antiarrhythmic  drugs  previously  ineffective.  Warfarin  was  continued  for  a 
minimum of 3 months after the ablation procedure and maintained afterwards according to the 
prevalent rhythm and CHADS2 score of the patients. Antiarrhythmic drugs were stopped after a 
blanking period of 2 months. Ambulatory electrocardiographic recorders were used to correlate 
symptoms with arrhythmia recurrence.  All patients enrolled underwent physical examination 
and Holter  recordings  at  1,  3,  6  months  and 1 year  after  the procedure and in  case of the  
occurrence  of  arrhythmic  symptoms.                                      
Primary  endpoint                                         
Ablation  was  considered  successful  in  the  absence  of  symptomatic  or  asymptomatic  atrial 
tachyarrhythmias lasting ≥ 30 s, identified on surface ECG, Holter monitoring or 7-day ECG 
recording, without antiarrhythmic drug therapy.                                             
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 10 (11): 486-495 (2010)
Antonio Sorgente, Gian Battista Chierchia, Lucio Capulzini, Yoshinao Yazaki,        490 
Andreas  Muller-Burri,  Fatih  Bayrak,  Andrea  Sarkozy,  Carlo  de  Asmundis,  Gaetano 
Paparella,  Pedro  Brugada,  “Atrial  Fibrillation  Ablation:  A  Single  Center  Comparison  
Between Remote Magnetic Navigation, Cryoballoon and Conventional Manual Pulmonary  
Vein Isolation”
Statistical  analysis                                         
Continuous  variables  are  expressed  as  mean  values  ±  standard  deviation,  and  were,  when 
appropriate, compared using the Student's t-test. Categorical variables are expressed as numbers 
and percentages and were, when appropriate, compared with the Pearson x2 analysis or Fisher's 
exact test. Predictive analysis of recurrence over the follow-up time was assessed through the 
Cox regression method. The multivariate model was used adjusting for AF type, sex, age ≥65 
years,  left  atrial  dimensions,  AF duration  before the index procedure,  antiarrhythmic  drugs, 
CAD, and procedure assignment. The hazard ratio (HR) and its 95% confidence interval (CI) 
were retrieved from the model. Kaplan–Meier event-free survival analysis was conducted to 
assess the cumulative freedom from recurrence. A p value <0.05 was considered statistically 
significant. SPSS, version 11.0 (SPSS, Inc., Chicago, IL, USA) was used for statistical analysis.
Results
A total of 267 patients affected by symptomatic drug refractory AF consecutively referred for an 
ablation to our department were screened for eligibility at our retrospective analysis. Of these 
patients,  80  were  excluded  because  they  had  already  undergone  a  previous  AF  ablation 
procedure in another center, 3 because of the occurrence of an acute complication that impeded 
procedure termination, 25 because of cross-over from rmtCPVI to mCPVI, 12 because of cross-
over from cCPVI to mCPVI, 15 because during ablation additional linear ablation or ablation of 
complex fractionated atrial electrograms (CFAE) were performed, 30 because of impossibility 
to  retrieve  information  about  their  follow-up  and  8  because  they  were  already  included  in 
another  ongoing  study  in  our  center.                                    
94 patients (79 males, 55.9 ± 9.8 years) were finally considered in our retrospective analysis. All 
patients  had  symptomatic  and  drug-resistant  AF  (75  paroxysmal,  16  persistent  and  3 
permanent). 92 patients underwent 24 hour Holter recordings at the time frame of 1, 3, 6 and 12 
months. Only 2 (1 in the group of the mCPVI and 1 in the group of cCPVI) underwent a 7 days  
ECG recording at the correspondent time period.  had Of them, 29 patients underwent mCPVI, 
30 cCPVI and 35 rmtCPVI. The baseline characteristics of the patients are shown in Table 1. 
No significant differences among the 3 groups in terms of sex, age, AF duration, LA size and 
left  ventricular  EF  were  present.  Follow-up  was  slightly  longer  in  patients  that  underwent 
cCPVI compared to patients who underwent mCPVI and rmtCPVI (p = 0.039). Procedural time 
and fluoroscopy time were  significantly  shorter  in  the  cCPVI group (both p < 0.001).  The 
procedural endpoint was achieved in every patient enrolled in the study (100%). At a mean 
follow-up of 12.64 ± 6.41 months (range 2-31), the success rate without antiarrhythmic therapy 
for mCPVI group was 65.5% (19 patients), 65.7 % (23 patients) for the cCPVI group and 66.7 
% (20 patients) for the rmtCPVI group (p = 0.625). The event-free survival estimates for the 3 
groups are reported in Figure 1. The event-free survival estimates for the 3 groups according to 
the  AF type  are  displayed  in  Figure  2.  Univariate  Cox regression  showed that  no  clinical 
variables were independently associated with recurrence (Figure 3). 
Complications
A left femoral artery pseudoaneurysm was found in 4 patients the day after the index procedure 
(2 in the mCPVI group, 1 in the cCPVI group and 1 in the rmtCPVI group). An arteriovenous 
fistula which required vascular intervention and a 2-day prolongation of hospitalization stay 
occurred  in  one  patient  of  the  mCPVI  group.  In  the  same  group,  moderate  asymptomatic 
pericardial effusion  was  documented  in  1  patient  the  day  after  procedure.  Serial 
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echocardiographic examinations showed complete resolution after 1 month. Transient phrenic 
nerve  palsy  was  observed  in  3  patients  when  delivering  cryothermal  energy  in  the  RSPV. 
Diaphragmatic  contraction  completely  recovered  before  the  end  of  the  procedure.  No 
cerebrovascular accident occurred during or after any procedure. 
Table 1. Baseline characteristics  of the patients
PAF: paroxysmal atrial fibrillation, PERSISTENT: persistent atrial fibrillation, PERMANENT: permanent atrial 
fibrillation, CAD: coronary artery disease, TIA: transient ischemic attack, P < 0.05 was considered as statistically 
significant.
Figure 1: Kaplan–Meier estimation of the time to atrial tachyarrhythmia recurrence after ablation in the 3 groups 
(mCPVI: black line, cCPVI: red line, rmtCPVI: green line).
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Figure 2: Kaplan–Meier estimation of the time to atrial tachyarrhythmia recurrence after ablation in the 3 groups 
according to the AF type (mCPVI: black line, cCPVI: red line, rmtCPVI: green line).
Figure 3: Hazard ratio from univariate Cox model of event-free survival. AF: atrial fibrillation; APLAD: 
anteroposterior left atrial diameter; IC: IC class antiarhhythmic drugs; CAD: coronary artery disease; HPT: arterial 
hypertension.
Discussion
To our knowledge this is the first single center study that compares the outcome of AF ablation 
following circumferential  PVI with 3 different  techniques.                                
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The main findings of our study are the following: 
1) At a mean follow-up of 1 year, approximately 65% of patients were free of symptomatic 
atrial  arrhythmias;                                             
2) There was no significant difference in terms of success rate among the 3 compared groups;
3) cCPVI proved to be associated with significantly shorter procedural times and lower X ray 
exposure;
4) No baseline population characteristics appeared to predict AF recurrence.
The overall proportion of patients free of symptomatic atrial arrhythmias at an average 1 year 
follow-up after a single PVI procedure was approximately 65%. This percentage is in line with 
previously published studies that  report  success  rates  of  one single procedure  of  AF ablation 
ranging between 56 and 88% [5-10]. This reasonably high percentage of arrhythmia free patients 
following  PVI  procedure  highlights  once  more  the  pivotal  role  played  by  these  anatomical 
structures in the genesis and maintenance of AF [1]. Furthermore, our population also included 
persistent and permanent variants of the arrhythmia which are known to be associated with lower 
success rates after ablation [10,11]. Success rate might have been higher if only patients affected 
by  paroxysmal  AF  had  been  included.                                            
Interestingly, there was no significant difference in success rate in the 3 groups. Our observation 
confirmed the efficacy of all 3 technologies in achieving PVI as already reported in the literature 
[1-4]. Recent studies aiming at comparing different technologies for AF have been published. 
Linhart et al [12]i reported similar findings when comparing cryoballoon with point by point RF 
PVI. In a relatively small study 40 patients were randomised to either cryoballoon ablation or 
manual RF ablation. At a follow-up of approximately 12 months roughly 50% of patients were 
free of AF and there was no significant difference in the 2 groups in terms of outcome.          
Recently Di Biase et al  [13] described their experience in a large cohort of patients with the 
Hansen robotic navigation system in comparison to manual AF ablation. The authors concluded 
that  robotic  navigation  system is  as  safe  and  effective  as  its  manual  counterpart.  However, 
physical  strain  and  X-ray  exposure  was  dramatically  reduced  resulting  in  enhanced  operator 
comfort, when the ablation was performed with the Hansen system. Up to date no prospective 
data comparing conventional manual with rmtCPVI ablation using an irrigated 3.5 mm tip RF 
catheter have been published. In our study, cCPVI had significantly shorter ablation procedure 
duration and lower X-ray exposure times as compared to the other 2 approaches. This might be 
explained by various  factors.  First,  in  the cCPVI group with the exception of  1 patient  who 
exhibited a left sided common ostium, all individuals had 4 distinct PV ostia. No patient had 
accessory  veins.  "Straightforward"  anatomies  might  prove  easier  when  performing  PVI  with 
"single" shot devices with consequent lower procedural times. As mentioned before, by its own 
nature cryoenergy tightly "sticks" to the tissue in contact. Thus, after demonstration of successful 
occlusion, cryoapplication can be started without the need of X-ray monitoring during most of the 
lesion formation time, as the cryoballoon will not loose its original position. This might give an 
explanation to the lower fluoroscopic times observed in the cCPVI group. Secondly, compared to 
the already published reports [3,14] in our center procedural and fluoroscopy times observed in 
the rmtCPVI and mCPVI groups were significantly higher. This finding can be explained by the 
fact that all the procedures were performed with the help of electrophysiological fellows and this 
can have increased procedural times and fluoroscopy times in the rmtCPVI and mCPVI groups.
Finally, in our study no baseline clinical parameters were predictors of failure to maintain sinus 
rhythm. This is line with a recent observation by Bertaglia and co-workers [15]. In our study, the 
rate of success at 12 months follow-up was similar among patients with paroxysmal, persistent 
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and  permanent  AF.  This  result  can  be  explained  considering  first  of  all  a  possible 
misclassification of paroxysmal atrial fibrillation as persistent atrial fibrillation occurred in a few 
selected cases (for example patients with episodes of AF shorter than 7 days, who underwent 
electrical  or pharmacological cardioversion due to symptoms or hemodynamic instability) and 
secondly  the  relatively  small  mean dimensions  of  the  LA in  our  study population  (41  mm).
Study  limitations                                 
The  most  important  limitation  of  our  study  is  its  retrospective  and  observational  design.  A 
randomized prospective study is actually ongoing in our center to add more data and to confirm 
the above described findings. Nevertheless, although only a small portion of the totality of PVI 
performed in our center was included in our analysis, it corresponds to a natural population of AF 
patients referred to our electrophysiological laboratory and gives a realistic picture of the mid-
term clinical results of 3 different techniques for atrial fibrillation ablation. Secondly the inference 
to general population is strongly limited by the single-center design of the study. Thus results 
might  not  be  generalized.                                    
Conclusions
RMT guided RF, manual conventional RF and cryoballoon ablation are all effective in producing 
PVI. Furthermore all  3 techniques have similar rates in terms of freedom of AF after 1 year 
follow-up with success rates approximating 65%. However, cryoballoon ablation might be faster 
and might expose the operator and the patient to lower irradiation as compared to the other 2 
approaches. No significant predictor of AF recurrence following ablation was observed in our 
population.  
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